(a) Subject to Subsection (b), the commission shall negotiate with manufacturers and labelers, including generic manufacturers and labelers, to obtain supplemental rebates for prescription drugs provided under:
- (1) the Medicaid vendor drug program in excess of the Medicaid rebates required by 42 U.S.C. Section 1396r-8;
- (2) the child health plan program; and
- (3) any other state program the commission or a health and human services agency administers, including a community mental health center or state mental health hospital.
- (b) The commission may by contract authorize a private entity to negotiate with manufacturers and labelers on the commission's behalf.
Added by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 1.01, eff. April 1, 2025.